Op deze pagina vindt u het laatste nieuws uit de wereld van klinisch onderzoek!
Nieuwsfeed
- RIVM registreert 8600 nieuwe coronagevallen
- TrialSite News Daily Digest
- Uitgelicht en gespot op internet (week 15, 2021)
- Petitie medewerkers Amphia Ziekenhuis tegen testfeest Breda
- Recursion founders gin fortunes as IPO backers shower $436M on one of the biggest boasts in AI -- based on some very small deals
- GLP-1 peptide analogs for targeting pancreatic beta cells
- European countries in the race to attract successful biopharma investment: winners and lagers
- Adjunctive therapy for multidrug-resistant bacterial infections: type III secretion system and efflux inhibitors
- Leucine as an excipient in spray dried powder for inhalation
- The era of gene therapy: From preclinical development to clinical application
- The fight against COVID-19: striking a balance in the renin–angiotensin system
- Weekend reads: ‘The Damage Campaign;’ timber industry retracts comments, apologizes; COVID-19 vaccine study conflicts disclosure
- Weekend reads: ‘The Damage Campaign;’ timber industry retracts comments, apologizes; COVID-19 vaccine study conflicts disclosure
- Despite resistance, researchers investigate possible new mental health disorder
- Voorzitter Rouvoet oneens met kritiek op GGD
- FNV heeft liever structureel hoger loon dan zorgbonus
- Covid-19 vaccine halt drags on, an FDA appointment at long last, the great CRO consolidation, and more
- De Jonge vraagt Zuyderland om begrip vaccinatiebeleid
- Ziekenhuispersoneel krijgt snel vaccin van Janssen of Pfizer
- TrialSite News Daily Digest
- US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009–2018
- Registration of clinical trials in Russia: How does it compare with the World Health Organization International Clinical Trials Registry Platform standards?
- Strategies for facilitating the delivery of cluster randomized trials in hospitals: A study informed by the CFIR-ERIC matching tool
- ANAVIP
- MDR/IVDR: Commission adopts new standardization request
- The latest from Pharmalot
- Durisan Announces a Voluntary Recall Expansion of its Antimicrobial Hand Sanitizer
- Durisan Hand Sanitizer Recall Due to Microbial Contamination
- Rare diseases, STAR expansion considered in PDUFA VII premarket negotiations
- Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab
- User Fee Lists
- Janssen COVID-19 Vaccine
- Some experts fear next-generation Covid vaccines may be worse; a biotech analyst talks pandemic drug development
- Public Notification: Triple SupremeZen Plus 3500 contains hidden drug ingredient
- Public Notification: Triple SupremeZen Extreme 3500 contains hidden drug ingredients
- Public Notification: Thumbs Up 7 Blue 69K contains hidden drug ingredients
- Public Notification: Thumbs Up 7 White 11K contains hidden drug ingredients
- Public Notification: Thumbs Up 7 Black 25K contains hidden drug ingredient
- Public Notification: Shogun-X Platinum 7000 contains hidden drug ingredients
- Public Notification: Rock Steady 72 Hours contains hidden drug ingredients
- Coronavirus (COVID-19) Update: April 16, 2021
- Coronavirus (COVID-19) Update: April 16, 2021
- Public Notification: Premier Platinum 5000 contains hidden drug ingredient
- Public Notification: PremierZen Extreme 3000 contains hidden drug ingredient
- What's New Related to Drugs
- Public Notification: Original White Dragon contains hidden drug ingredients
- Public Notification: Krazy Night contains hidden drug ingredient
- Public Notification: Kopi Jantan Tradisional Natural Herbs Coffee contains hidden drug ingredient
- Public Notification: Imperial Platinum 2000 contains hidden drug ingredient
- Public Notification: Imperial Gold 2000 contains hidden drug ingredients